Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample

Imagem de Miniatura
Arquivos
art_PARADELA_Association_between_APOEε4_allele_and_cognitive_function_is_2023.PDF (998.66 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
GRINBERG, Lea T.
NASLAVSKY, Michel Satya
ZATZ, Mayana
Citação
ACTA NEUROPATHOLOGICA COMMUNICATIONS, v.11, n.1, article ID 205, 10p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Apolipoprotein E epsilon 4 allele (APOE-epsilon 4) is the main genetic risk factor for late-onset Alzheimer's disease (AD) and may impact cognitive function also via other neuropathological lesions. However, there is limited evidence available from diverse populations, as APOE associations with dementia seem to differ by race. Therefore, we aimed to evaluate the pathways linking APOE-epsilon 4 to cognitive abilities through AD and non-AD neuropathology in an autopsy study with an admixed sample.Methods: Neuropathological lesions were evaluated following international criteria using immunohistochemistry. Participants were classified into APOE-epsilon 4 carriers (at least one epsilon 4 allele) and non-carriers. Cognitive abilities were evaluated by the Clinical Dementia Rating Scale sum of boxes. Mediation analyses were conducted to assess the indirect association of APOE-epsilon 4 with cognition through AD-pathology, lacunar infarcts, hyaline arteriosclerosis, cerebral amyloid angiopathy (CAA), Lewy body disease (LBD), and TAR DNA-binding protein 43 (TDP-43).Results: We included 648 participants (mean age 75 +/- 12 years old, mean education 4.4 +/- 3.7 years, 52% women, 69% White, and 28% APOE-epsilon 4 carriers). The association between APOE-epsilon 4 and cognitive abilities was mediated by neurofibrillary tangles (beta = 0.88, 95% CI = 0.45; 1.38, p < 0.001) and neuritic plaques (beta = 1.36, 95% CI = 0.86; 1.96, p < 0.001). Lacunar infarcts, hyaline arteriosclerosis, CAA, LBD, and TDP-43 were not mediators in the pathway from APOE-epsilon 4 to cognition.Conclusion: The association between APOE-epsilon 4 and cognitive abilities was partially mediated by AD-pathology. On the other hand, cerebrovascular lesions and other neurodegenerative diseases did not mediate the association between APOE-epsilon 4 and cognition.
Palavras-chave
Apolipoprotein E, Cognition, Dementia, Neuritic plaques, Neurofibrillary tangles, Mediation analysis
URI
https://observatorio.fm.usp.br/handle/OPI/58031
Referências
  1. Arboleda-Velasquez JF, 2019, NAT MED, V25, P1680, DOI 10.1038/s41591-019-0611-3
  2. Baek MS, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00710-6
  3. Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934
  4. Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
  5. BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
  6. Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z
  7. Cai WJ, 2023, BIOMOLECULES, V13, DOI 10.3390/biom13020313
  8. CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
  9. Davis AA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay3069
  10. Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487
  11. Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041
  12. Fyfe I, 2018, NAT REV NEUROL, V14, P570, DOI 10.1038/s41582-018-0064-1
  13. Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252
  14. Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
  15. Hanseeuw BJ, 2019, JAMA NEUROL, V76, P915, DOI 10.1001/jamaneurol.2019.1424
  16. Itoh Y, 1996, STROKE, V27, P216, DOI 10.1161/01.STR.27.2.216
  17. Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y
  18. Jin YJ, 2022, ACTA NEUROPATHOL, V143, P641, DOI 10.1007/s00401-022-02421-8
  19. Jung JH, 2021, NEUROBIOL AGING, V106, P45, DOI 10.1016/j.neurobiolaging.2021.06.004
  20. Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127
  21. Lamar M, 2019, ALZHEIMERS DEMENT, V15, P258, DOI 10.1016/j.jalz.2018.08.007
  22. Lee H, 2021, JAMA-J AM MED ASSOC, V326, P1045, DOI 10.1001/jama.2021.14075
  23. Loika Y, 2022, GEROSCIENCE, V44, P1141, DOI 10.1007/s11357-021-00458-3
  24. MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
  25. Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406
  26. Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
  27. MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
  28. Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855
  29. Murayama S, 2004, NEUROPATHOLOGY, V24, P254, DOI 10.1111/j.1440-1789.2004.00571.x
  30. Naslavsky MS, 2022, MOL PSYCHIATR, V27, P4800, DOI 10.1038/s41380-022-01729-x
  31. Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y
  32. Nelson PT, 2013, J NEUROPATH EXP NEUR, V72, P708, DOI 10.1097/NEN.0b013e31829a25b9
  33. Nichols E, 2022, ALZHEIMERS DEMENT, DOI 10.1002/alz.12885
  34. O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091
  35. Riddell DR, 1997, J BIOL CHEM, V272, P89
  36. Ruffmann C, 2016, NEUROPATH APPL NEURO, V42, P436, DOI 10.1111/nan.12294
  37. Sawyer K, 2009, GERONTOLOGY, V55, P32, DOI 10.1159/000137666
  38. Schneider JA, 2005, STROKE, V36, P954, DOI 10.1161/01.STR.0000160747.27470.2a
  39. Suemoto CK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002267
  40. Tingley D, 2014, J STAT SOFTW, V59
  41. VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402
  42. Wang SS, 2023, NEUROSCI LETT, V796, DOI 10.1016/j.neulet.2023.137052
  43. Weigand AJ, 2021, ALZHEIMERS DEMENT, V17, P61, DOI 10.1002/alz.12173
  44. Yang HS, 2018, LANCET NEUROL, V17, P773, DOI 10.1016/S1474-4422(18)30251-5
  45. Yu L, 2015, NEUROBIOL AGING, V36, P2946, DOI 10.1016/j.neurobiolaging.2015.08.008

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/22
Carregar mais